William E. Rote

2.4k total citations
35 papers, 1.5k citations indexed

About

William E. Rote is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Internal Medicine. According to data from OpenAlex, William E. Rote has authored 35 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 18 papers in Cardiology and Cardiovascular Medicine and 6 papers in Internal Medicine. Recurrent topics in William E. Rote's work include Blood Coagulation and Thrombosis Mechanisms (20 papers), Atrial Fibrillation Management and Outcomes (9 papers) and Hemophilia Treatment and Research (7 papers). William E. Rote is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (20 papers), Atrial Fibrillation Management and Outcomes (9 papers) and Hemophilia Treatment and Research (7 papers). William E. Rote collaborates with scholars based in United States, Netherlands and Australia. William E. Rote's co-authors include George P. Vlasuk, Benedict R. Lucchesi, Marcel Levi, Joan B. Geisbert, Lisa E. Hensley, T. Fredeking, Peter B. Jahrling, Thomas W. Geisbert, Howard A. Young and Jason Paragas and has published in prestigious journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

In The Last Decade

William E. Rote

35 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William E. Rote United States	21	556	318	318	283	239	35	1.5k
Lea M. Beaulieu United States	19	743 1.3×	133 0.4×	208 0.7×	129 0.5×	586 2.5×	23	1.8k
Cristina Lupu United States	22	593 1.1×	75 0.2×	192 0.6×	150 0.5×	340 1.4×	49	1.5k
Stephen H. Norris United States	14	113 0.2×	339 1.1×	517 1.6×	363 1.3×	157 0.7×	23	1.5k
M. Henry France	18	310 0.6×	211 0.7×	211 0.7×	59 0.2×	205 0.9×	28	1.5k
Gabriela Cesarman‐Maus Mexico	13	424 0.8×	46 0.1×	189 0.6×	349 1.2×	275 1.2×	31	1.3k
Roger J. S. Preston Ireland	27	1.1k 1.9×	74 0.2×	193 0.6×	189 0.7×	266 1.1×	75	1.9k
Pascale E. P. Dekkers Netherlands	16	358 0.6×	117 0.4×	56 0.2×	169 0.6×	168 0.7×	34	1.2k
A. J. M. Eerenberg Netherlands	19	442 0.8×	150 0.5×	81 0.3×	66 0.2×	280 1.2×	21	1.8k
Gary Sinclair Canada	13	740 1.3×	135 0.4×	101 0.3×	100 0.4×	578 2.4×	25	2.3k
Peter A. von dem Borne Netherlands	26	1.4k 2.5×	251 0.8×	185 0.6×	105 0.4×	327 1.4×	96	2.4k

Countries citing papers authored by William E. Rote

Since Specialization

Citations

This map shows the geographic impact of William E. Rote's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William E. Rote with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William E. Rote more than expected).

Fields of papers citing papers by William E. Rote

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William E. Rote. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William E. Rote. The network helps show where William E. Rote may publish in the future.

Co-authorship network of co-authors of William E. Rote

This figure shows the co-authorship network connecting the top 25 collaborators of William E. Rote. A scholar is included among the top collaborators of William E. Rote based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William E. Rote. William E. Rote is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Trachtman, Howard, Jai Radhakrishnan, Michelle N. Rheault, et al.. (2024). Focal Segmental Glomerulosclerosis Patient Baseline Characteristics in the Sparsentan Phase 3 DUPLEX Study. Kidney International Reports. 9(4). 1020–1030. 2 indexed citations

Barratt, Jonathan, Brad H. Rovin, Muh Geot Wong, et al.. (2023). IgA Nephropathy Patient Baseline Characteristics in the Sparsentan PROTECT Study. Kidney International Reports. 8(5). 1043–1056. 20 indexed citations

Komers, Radko, Ulysses Diva, Jula K. Inrig, et al.. (2020). Study Design of the Phase 3 Sparsentan Versus Irbesartan (DUPLEX) Study in Patients With Focal Segmental Glomerulosclerosis. Kidney International Reports. 5(4). 494–502. 40 indexed citations

Pont, Anne-Cornélie J. M., Kamran Bakhtiari, Barbara A. Hutten, et al.. (2006). Endotoxaemia induces resistance to activated protein C in healthy humans. British Journal of Haematology. 134(2). 213–219. 15 indexed citations

Rijneveld, Anita W., Sebastiaan Weijer, Paul Bresser, et al.. (2006). Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia*. Critical Care Medicine. 34(6). 1725–1730. 62 indexed citations

Florquin, Sandrine, Marcel Levi, George P. Vlasuk, et al.. (2004). Inhibition of the Tissue Factor/Factor VIIa Pathway Does Not Influence the Inflammatory or Antibacterial Response to Abdominal Sepsis Induced byEscherichia coliin Mice. The Journal of Infectious Diseases. 189(12). 2308–2317. 43 indexed citations

Jonge, Evert de, Joost C.M. Meijers, G P Vlasuk, et al.. (2004). Recombinant nematode anticoagulant protein c2, an inhibitor of tissue factor/factor VIIa, attenuates coagulation and the interleukin‐10 response in human endotoxemia. Journal of Thrombosis and Haemostasis. 2(1). 65–70. 32 indexed citations

Geisbert, Thomas W., Lisa E. Hensley, Peter B. Jahrling, et al.. (2003). Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys. The Lancet. 362(9400). 1953–1958. 295 indexed citations

Moons, Arno H., Ron J.G. Peters, Nick R. Bijsterveld, et al.. (2003). Recombinant nematode anticoagulant protein c2, an inhibitor of the tissue factor/factor VIIa complex, in patients undergoing elective coronary angioplastyAppendix. Journal of the American College of Cardiology. 41(12). 2147–2153. 77 indexed citations

10.

Bijsterveld, Nick R., H.R. Büller, Martin H. Prins, et al.. (2002). A blinded multicenter dose escalation phase IIa study of the factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in patients undergoing elective percutaneous coronary intervention. Journal of the American College of Cardiology. 39. 16–16. 1 indexed citations

11.

Jiang, Ning, Matthew Moyle, Howard R. Soule, William E. Rote, & Michael Chopp. (1995). Neutrophil inhibitory factor is neuroprotective after focal Ischemia in rats. Annals of Neurology. 38(6). 935–942. 120 indexed citations

12.

Trikha, Mohit, William E. Rote, Peter J. Manley, Benedict R. Lucchesi, & Francis S. Markland. (1994). Purification and characterization of platelet aggregation inhibitors from snake venoms. Thrombosis Research. 73(1). 39–52. 58 indexed citations

13.

Werns, S.W., et al.. (1994). Nitroglycerin inhibits experimental thrombosis and reocclusion after thrombolysis. American Heart Journal. 127(4). 727–737. 13 indexed citations

14.

Rote, William E., James H. Davis, Shaker A. Mousa, Thomas M. Reilly, & Benedict R. Lucchesi. (1994). Antithrombotic Effects of DMP 728, a Platelet GPIIb/IIIa Receptor Antagonist, in a Canine Model of Arterial Thrombosis. Journal of Cardiovascular Pharmacology. 23(4). 681–689. 16 indexed citations

15.

Rote, William E., et al.. (1994). Prevention of Rethrombosis After Coronary Thrombolysis in a Chronic Canine Model. II. Adjunctive Therapy with r-Hirudin. Journal of Cardiovascular Pharmacology. 23(2). 203–211. 8 indexed citations

16.

Rote, William E., et al.. (1994). Chimeric 7E3 prevents carotid artery thrombosis in cynomolgus monkeys.. Stroke. 25(6). 1223–1232. 23 indexed citations

17.

Rote, William E., S.W. Werns, James H. Davis, et al.. (1993). Platelet GPIIb/IIIa receptor inhibition by SC-49992 prevents thrombosis and rethrombosis in the canine carotid artery. Cardiovascular Research. 27(3). 500–507. 24 indexed citations

18.

Rote, William E., et al.. (1993). Thromboxane antagonism in experimental canine carotid artery thrombosis.. Stroke. 24(6). 820–827. 10 indexed citations

19.

Rote, William E., et al.. (1993). Prevention of experimental carotid artery thrombosis by applaggin.. Journal of Pharmacology and Experimental Therapeutics. 267(2). 809–814. 10 indexed citations

20.

Rote, William E. & John D. Connor. (1992). Autonomic mechanisms in heart rate variability after isoproterenol-induced myocardial damage in rats. Journal of the Autonomic Nervous System. 38(1). 37–44. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact